Bristol-Myers Squibb Board of Directors Sends Letter to Shareholders

Bristol-Myers Squibb Company’s BMY, -1.55% Board of Directors today sent an open letter to the Company’s shareholders regarding the previously announced definitive merger agreement with Celgene Corporation CELG, -1.65% In addition to its March 19 investor presentation, the Company today also made available on Bristol-Myers Squibb’s website ...
Login to comment.